Co-living

Will co-living prove to be a permanent fixture?
Sector activity has increased despite downturn, but planning and management worries remain

UK and Spain are top targets for living investors
Germany falls to third place, according to Cushman survey
Latest Articles

GNM Developments lodges plans for £60m Birmingham tower
52 Gas Street scheme would deliver the world's tallest energy-positive development

Amro Partners submits plans for £250m Sutton residential scheme
Former 200,000 sq ft office building to be redeveloped and offer more than 500 homes

Investec lends £17m for Birmingham co-living scheme
Funding in place for 150-home city centre project

Packaged Living teams up with Buccleuch for £40m co-living debut
Woolwich scheme will be third companies have partnered on
-
-
Life sciences
Golden Triangle take-up dips but Cambridge leads charge
-
Corporate
Avison Young’s Nick Walkley: “If you’re not in the big four, you can afford to take risks”
-
Retail
New asset manager takes the reins for one of UK’s biggest shopping malls
-
Opinion
How Heathrow expansion puts London’s industrial market in play
-
Hotels & Leisure
£400m boutique hotel business on the block
-
Residential
Green light for Criterion’s Camberwell Magistrates’ Court overhaul
-
Residential
GLA taps Vistry Group for Enfield scheme
-
Corporate
Knight Frank forms UK board and appoints adviser
-
People
Cushman’s APAC chief expands role to include EMEA
-
Office
South Bank office development pipeline biggest in London
-
Corporate
Patrizia’s UK heads depart
-
Corporate
LaSalle star Zerda to leave
-
London
Ares extends acquisitive run with £100m West End purchase
-
Corporate
Former KKR UK head scores with Neville and Fora
-
London
UK law firm shortlists trio for 300,000 sq ft London HQ hunt
-
Logistics
Chinese giant circles £650m airport portfolio
-
London
Former Oxford Street Debenhams offices fully let
-
London
UK law firm eyes 180,000 sq ft London HQ move
-
People
CBRE’s Ciaran Bird announces departure
-
Logistics
Greykite launches multi-let industrial platform with €1bn ambitions
-
Life sciences